BUFFALO, NY--(Marketwire - December 13, 2007) - Cleveland BioLabs, Inc. (NASDAQ: CBLI), today announced that it will host a conference call to update investors on the progress of its clinical programs, research and development efforts, corporate developments, and the status of the Company’s pending contract with the Department of Defense (DoD).
